|
NMRAL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.18713935851156E-14 |
| Normal-vs-Stage2 |
1.043680E-02 |
| Normal-vs-Stage3 |
9.829200E-04 |
| Normal-vs-Stage4 |
6.547900E-02 |
| Stage1-vs-Stage2 |
1.483440E-01 |
| Stage1-vs-Stage3 |
3.632200E-01 |
| Stage1-vs-Stage4 |
2.667200E-01 |
| Stage2-vs-Stage3 |
5.577400E-01 |
| Stage2-vs-Stage4 |
9.663800E-01 |
| Stage3-vs-Stage4 |
6.138800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
3.156100E-03 |
| Normal-vs-Asian |
1.151240E-01 |
| Caucasian-vs-AfricanAmerican |
2.557400E-03 |
| Caucasian-vs-Asian |
7.677200E-01 |
| AfricanAmerican-vs-Asian |
5.031000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
3.576400E-04 |
| Male-vs-Female |
8.664500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.190290E-04 |
| Normal-vs-Extreme_Weight |
2.17381668221606E-13 |
| Normal-vs-Obese |
9.84769999989865E-07 |
| Normal-vs-Extreme_Obese |
9.785600E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.854000E-02 |
| Normal_Weight-vs-Obese |
4.493000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.613200E-01 |
| Extreme_Weight-vs-Obese |
4.443400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.027820E-01 |
| Obese-vs-Extreme_Obese |
3.501400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.468800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.4793500585929E-12 |
| Normal-vs-Age(61-80Yrs) |
2.33146835171283E-15 |
| Normal-vs-Age(81-100Yrs) |
8.787500E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.954200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.494500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.158000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.271800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.977000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.150960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
2.46359999999113E-05 |
| Normal-VS-KIRP CIMP |
9.156200E-01 |
| Normal-VS-Unclassified PRCC |
2.21069999994938E-06 |
| Type1 PRCC-VS-Type2 PRCC |
1.615140E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.038300E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.158400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.401700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.637800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.296490E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23860000034171E-07 |
| Normal-vs-N1 |
1.126100E-02 |
| Normal-vs-N2 |
6.157400E-01 |
| N0-vs-N1 |
3.705400E-01 |
| N0-vs-N2 |
3.240400E-01 |
| N1-vs-N2 |
6.417200E-01 |
|
|
